BRADLEY WILLIAM 4
4 · FRACTYL HEALTH, INC. · Filed Jun 11, 2026
Research Summary
AI-generated summary of this filing
Fractyl Health (GUTS) Director Bradley William Buys Stock
What Happened
Bradley William, a director of Fractyl Health, made an open-market purchase of 68,493 shares at $0.73 per share on 2026-06-10 for a total of $50,329. On the same date he was also granted a 22,500-share stock option award (derivative) valued at $0.00 in the filing.
Key Details
- Transaction date(s): 2026-06-10; Filing date: 2026-06-11 (appears timely).
- Open-market purchase (code P): 68,493 shares @ $0.73 = $50,329. (Footnote F1: open market purchase.)
- Award/grant (code A): 22,500-share option award @ $0.00 (derivative). (Footnote F2: non-employee director compensation.)
- Vesting for the option award: vests in a single installment on the earlier of the next annual meeting or one year from grant, subject to continued board service.
- Shares owned after the transaction: not specified in the information provided.
Context
The purchase is an outright open-market buy (direct equity purchase), which some investors view as a stronger signal than awards, though filings do not reveal motive. The 22,500-share item is an awarded option that will vest in the future if the director remains in service; it is not an immediate exercise or sale.
Insider Transaction Report
Form 4
BRADLEY WILLIAM
Director
Transactions
- Purchase
Common Stock
[F1]2026-06-10$0.73/sh+68,493$50,329→ 84,622 total - Award
Stock Option
[F2]2026-06-10+22,500→ 22,500 totalExercise: $0.73Exp: 2036-06-09→ Common Stock (22,500 underlying)
Footnotes (2)
- [F1]Open market purchase.
- [F2]The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant, in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date.
Signature
/s/ Harith Rajagopalan, M.D., Ph.D., Attorney-in-fact|2026-06-11